Aphria RX, the Neumünster, Germany-based subsidiary of Tilray Brands, announced Monday it received a medical marijuana cultivation license under the European country’s new Cannabis Act.
Tilray, based in Leamington, Ontario, Canada, and New York, said in a Monday news release the cultivation permit was the first to be issued under Germany’s new recreational cannabis law, which took effect April 1.
ADVERTISEMENT
The new law, approved Feb. 23, among other things, removed marijuana from the narcotics list, legalized possession for adults of up to 25 grams (0.88 ounces), allowed for “cannabis clubs” – one has already been approved for a permit – and amended Germany’s Medicinal Cannabis Act (MedCanG).
New medical cannabis provisions
Under the MedCanG amendments, according to the ECA Academy, operators seeking to
Read full article on Marijuana Business Daily
